Why is BioLife Solutions, Inc. ?
1
With a growth in Net Sales of 46.39%, the company declared Outstanding results in Mar 26
- The company has declared positive results for the last 3 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 17.9 MM
- ROCE(HY) Highest at -2.9%
- PRE-TAX PROFIT(Q) At USD 1.25 MM has Grown at 141.32%
2
High Institutional Holdings at 100%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
How much should you buy?
- Overall Portfolio exposure to BioLife Solutions, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is BioLife Solutions, Inc. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
BioLife Solutions, Inc.
21.0%
0.47
44.93%
S&P 500
25.41%
1.92
13.25%
Quality key factors
Factor
Value
Sales Growth (5y)
14.88%
EBIT Growth (5y)
-224.57%
EBIT to Interest (avg)
-24.47
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.21
Sales to Capital Employed (avg)
0.28
Tax Ratio
1.27%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.41
EV to EBIT
-49.16
EV to EBITDA
-68.50
EV to Capital Employed
2.81
EV to Sales
8.48
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-5.72%
ROE (Latest)
-3.26%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
Mildly Bullish
Technical Movement
23What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 17.9 MM
ROCE(HY)
Highest at -2.9%
PRE-TAX PROFIT(Q)
At USD 1.25 MM has Grown at 141.32%
NET PROFIT(Q)
At USD 1.19 MM has Grown at 139.11%
DEBT-EQUITY RATIO
(HY)
Lowest at -17.77 %
DEBTORS TURNOVER RATIO(HY)
Highest at 8.98 times
EPS(Q)
Highest at USD 0.02
-1What is not working for the Company
RAW MATERIAL COST(Y)
Grown by 5.32% (YoY
Here's what is working for BioLife Solutions, Inc.
Operating Cash Flow
Highest at USD 17.9 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Pre-Tax Profit
At USD 1.25 MM has Grown at 141.32%
over average net sales of the previous four periods of USD -3.02 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Net Profit
At USD 1.19 MM has Grown at 139.11%
over average net sales of the previous four periods of USD -3.03 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
EPS
Highest at USD 0.02
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Debt-Equity Ratio
Lowest at -17.77 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Debtors Turnover Ratio
Highest at 8.98 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Here's what is not working for BioLife Solutions, Inc.
Raw Material Cost
Grown by 5.32% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






